Dutch guidelines for diagnosis and treatment of chronic lymphocytic leukaemia 2011

A. P. Kater; S. Wittebol; M. E. D. Chamuleau; M. van Gelder; M. H J van Oers

Dutch guidelines for diagnosis and treatment of chronic lymphocytic leukaemia 2011

A. P. Kater^*, S. Wittebol, M. E. D. Chamuleau, M. van Gelder, M. H J van Oers

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

One of the principal responsibilities of the Chronic Lymphocytic Leukaemia (CLL) Working Party of the Dutch/Belgium Haemato-Oncology Foundation for Adults in the Netherlands (HOVON) is to create up-to-date guidelines for CLL. In this article, the revised guidelines for diagnosis and treatment are summarised. Despite recent expansion in treatment options for patients with CLL, the disease remains incurable in most cases and the optimal treatment approach for several subgroups of patients is still unclear. Therefore, it remains highly important to treat patients within clinical studies as much as possible. In this article, the current studies initiated by the HOVON CLL working party are emphasised.

Original language	English
Pages (from-to)	422-429
Journal	Netherlands Journal of Medicine
Volume	69
Issue number	10
Publication status	Published - Oct 2011

Keywords

Chronic lymphocytic leukaemia
guidelines
HOVON

Cite this

@article{87913b6ee97e438b86f02751d66c03d2,

title = "Dutch guidelines for diagnosis and treatment of chronic lymphocytic leukaemia 2011",

abstract = "One of the principal responsibilities of the Chronic Lymphocytic Leukaemia (CLL) Working Party of the Dutch/Belgium Haemato-Oncology Foundation for Adults in the Netherlands (HOVON) is to create up-to-date guidelines for CLL. In this article, the revised guidelines for diagnosis and treatment are summarised. Despite recent expansion in treatment options for patients with CLL, the disease remains incurable in most cases and the optimal treatment approach for several subgroups of patients is still unclear. Therefore, it remains highly important to treat patients within clinical studies as much as possible. In this article, the current studies initiated by the HOVON CLL working party are emphasised.",

keywords = "Chronic lymphocytic leukaemia, guidelines, HOVON",

author = "Kater, {A. P.} and S. Wittebol and Chamuleau, {M. E. D.} and {van Gelder}, M. and {van Oers}, {M. H J}",

year = "2011",

month = oct,

language = "English",

volume = "69",

pages = "422--429",

journal = "Netherlands Journal of Medicine",

issn = "0300-2977",

publisher = "Van Zuiden Communications",

number = "10",

}

TY - JOUR

T1 - Dutch guidelines for diagnosis and treatment of chronic lymphocytic leukaemia 2011

AU - Kater, A. P.

AU - Wittebol, S.

AU - Chamuleau, M. E. D.

AU - van Gelder, M.

AU - van Oers, M. H J

PY - 2011/10

Y1 - 2011/10

N2 - One of the principal responsibilities of the Chronic Lymphocytic Leukaemia (CLL) Working Party of the Dutch/Belgium Haemato-Oncology Foundation for Adults in the Netherlands (HOVON) is to create up-to-date guidelines for CLL. In this article, the revised guidelines for diagnosis and treatment are summarised. Despite recent expansion in treatment options for patients with CLL, the disease remains incurable in most cases and the optimal treatment approach for several subgroups of patients is still unclear. Therefore, it remains highly important to treat patients within clinical studies as much as possible. In this article, the current studies initiated by the HOVON CLL working party are emphasised.

AB - One of the principal responsibilities of the Chronic Lymphocytic Leukaemia (CLL) Working Party of the Dutch/Belgium Haemato-Oncology Foundation for Adults in the Netherlands (HOVON) is to create up-to-date guidelines for CLL. In this article, the revised guidelines for diagnosis and treatment are summarised. Despite recent expansion in treatment options for patients with CLL, the disease remains incurable in most cases and the optimal treatment approach for several subgroups of patients is still unclear. Therefore, it remains highly important to treat patients within clinical studies as much as possible. In this article, the current studies initiated by the HOVON CLL working party are emphasised.

KW - Chronic lymphocytic leukaemia

KW - guidelines

KW - HOVON

M3 - Article

SN - 0300-2977

VL - 69

SP - 422

EP - 429

JO - Netherlands Journal of Medicine

JF - Netherlands Journal of Medicine

IS - 10

ER -